Onderneming Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Aandelen
301246
CNE100005ZB9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,82 CNY | -3,70% | -3,77% | -42,96% |
Vakgebied
Aantal werknemers: 2 075
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Raw Materials and Pharmaceuticals Intermediates
44,7
%
| 946 | 45,9 % | 919 | 44,7 % | -2,85% |
Lithium Battery Material
38,1
%
| 738 | 35,7 % | 784 | 38,1 % | +6,23% |
Organic Chemical Raw Materials
10,7
%
| 263 | 12,8 % | 220 | 10,7 % | -16,50% |
Pharmaceutical Preparations
4,5
%
| 82 | 4,0 % | 92 | 4,5 % | +12,87% |
Others
1,9
%
| 34 | 1,7 % | 39 | 1,9 % | +14,67% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
85,3
%
| 1 677 | 81,3 % | 1 753 | 85,3 % | +4,48% |
Overseas
14,7
%
| 386 | 18,7 % | 302 | 14,7 % | -21,75% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Xiao Hui Li
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Xiao Liu Duan
BRD | Director/Board Member | 59 | - |
Ying Yao
BRD | Director/Board Member | 37 | - |
Zhan Liang Liu
BRD | Director/Board Member | 58 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Dan Yin
IRC | Investor Relations Contact | 36 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qing Xie
BRD | Director/Board Member | 61 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Guo Ping Yin
FOU | Founder | 64 | 21-01-02 |
Xiao Hui Yan
BRD | Director/Board Member | 53 | - |
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Zhan Liang Liu
BRD | Director/Board Member | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Xiao Liu Duan
BRD | Director/Board Member | 59 | - |
Lin Tao Wang
BRD | Director/Board Member | 54 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 400 006 800 | 149 298 058 ( 37,32 %) | 0 | 37,32 % |
Bedrijfsgegevens
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Economic Development Zone Fengshan Town
438600, Huanggang
+86 71 3507 2024
http://www.hbhypharm.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,96% | 818 mln. | |
+42,27% | 748 mld. | |
+33,99% | 598 mld. | |
-5,93% | 356 mld. | |
+18,36% | 325 mld. | |
+4,79% | 283 mld. | |
+17,40% | 245 mld. | |
+9,07% | 211 mld. | |
-4,34% | 209 mld. | |
+2,69% | 166 mld. |
- Beurs
- Aandelen
- Koers 301246
- Onderneming Hubei Hongyuan Pharmaceutical Technology Co., Ltd.